Astrocyte adaptation in Alzheimer's disease: a focus on astrocytic P2X7R

P Beltran-Lobo, MJ Reid… - Essays in …, 2023 - portlandpress.com
Astrocytes are key homeostatic and defensive cells of the central nervous system (CNS).
They undertake numerous functions during development and in adulthood to support and …

The P2X7 receptor, a multifaceted receptor in Alzheimer's disease

KE Ronning, PA Déchelle-Marquet, Y Che… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
impaired episodic memory and two pathological lesions: amyloid plaques and neurofibrillary …

[HTML][HTML] P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes

P Beltran-Lobo, MM Hughes, C Troakes… - Brain, Behavior, and …, 2023 - Elsevier
Abstract The purinoceptor P2X 7 R is a promising therapeutic target for tauopathies,
including Alzheimer's disease (AD). Pharmacological inhibition or genetic knockdown of …

P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer's disease

C Bianchi, B Alvarez-Castelao… - Alzheimer's Research & …, 2023 - Springer
Background Over recent years, increasing evidence suggests a causal relationship between
neurofibrillary tangles (NFTs) formation, the main histopathological hallmark of tauopathies …

Unlocking the therapeutic potential of P2X7 receptor: A comprehensive review of its role in neurodegenerative disorders

X Liu, Y Li, L Huang, Y Kuang, X Wu, X Ma… - Frontiers in …, 2024 - frontiersin.org
The P2X7 receptor (P2X7R), an ATP-gated ion channel, has emerged as a crucial player in
neuroinflammation and a promising therapeutic target for neurodegenerative disorders. This …

[HTML][HTML] P2 receptor-mediated signaling in the physiological and pathological brain: From development to aging and disease

P Mut-Arbona, B Sperlágh - Neuropharmacology, 2023 - Elsevier
The purinergic pathway mediates both pro-inflammatory and anti-inflammatory responses,
whereas the breakdown of adenosine triphosphate (ATP) is in a critical equilibrium. Under …

TNAP and P2X7R: New Plasma Biomarkers for Alzheimer's Disease

P Aivar, C Bianchi, C Di Lauro, L Soria-Tobar… - International Journal of …, 2023 - mdpi.com
Over the last few years, intense research efforts have been made to anticipate or improve
the diagnosis of Alzheimer's disease by detecting blood biomarkers. However, the most …

The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state

YH Ahn, Y Tang, P Illes - Expert Opinion on Therapeutic Targets, 2023 - Taylor & Francis
Introduction Astrocytes have previously been considered as cells supporting neuronal
functions, but they are now recognized as active players in maintaining central nervous …

P2X7 receptor: an emerging target in Alzheimer's disease

Q Huang, J Ying, W Yu, Y Dong, H Xiong… - Molecular …, 2024 - Springer
Alzheimer's disease (AD) is a major cause of age-related dementia, which is becoming a
global health crisis. However, the pathogenesis and etiology of AD are still not fully …

P2X7 Receptor and Extracellular Vesicle Release

MT Golia, M Gabrielli, C Verderio - International Journal of Molecular …, 2023 - mdpi.com
Extensive evidence indicates that the activation of the P2X7 receptor (P2X7R), an ATP-
gated ion channel highly expressed in immune and brain cells, is strictly associated with the …